Posttranslational Modification Cross‐Talk in Vascular Cells: Molecular Mechanisms and Therapeutic Implications for Atherosclerosis
Cell Biochemistry and Function · 2026-11 · 44 (11)
DOI: 10.1002/cbf.70329 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cell Biochemistry and Function, online erschienen am 01.11.2026. Verfasst von Weiwei Jiang und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiovascular Medicine, The 970th Hospital of the Joint Logistic Support Force of the People's Liberation Army, Yantai, China. Hauptthemen laut MEDLINE: Protein Processing, Post-Translational, Atherosclerosis, Endothelial Cells, Muscle, Smooth, Vascular. Die Arbeit nennt 217 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Atherosclerosis is driven by coordinated changes in endothelial cells (ECs), macrophages, and vascular smooth muscle cells (VSMCs). Post‐translational modifications (PTMs), phosphorylation, acetylation, ubiquitination, SUMOylation, O‐GlcNAcylation, palmitoylation, ISGylation, and ADP‐ribosylation, integrate metabolic, inflammatory, and mechanical inputs at a limited number of signaling nodes. This review argues that these modifications interact according to four definable relationships rather than merely co‐occurring. In competitive cross‐talk, two marks contest one acceptor residue, as when O‐GlcNAcylation displaces phosphorylation at the Akt site of endothelial nitric oxide synthase. In hierarchical cross‐talk, one modification licenses another, as when Ser536 phosphorylation of NF‐κB p65 recruits p300 and permits Lys310 acetylation. In enzyme‐directed cross‐talk, a modification acts on the writer or eraser of a different system, as HDAC9 does on IκB kinases. In cofactor‐coupled cross‐talk, sirtuin‐dependent deacylation and PARP1‐dependent ADP‐ribosylation draw on one limiting NAD + pool. We rank nodes against four stated criteria, grade every finding on a five‐level evidence scheme, and apply the framework to phosphorylation–O‐GlcNAcylation, ubiquitination–SUMOylation, and acetylation–ubiquitination interactions across the three vascular cell types. Of the cross‐talk relationships invoked, five are supported at residue resolution by a substitution experiment, and two of these were obtained in vascular cells; the remainder are inferred from enzyme‐level regulation or from pathway convergence. Candidate intervention points include HDAC9, SENP3, OGT, UBA1, and the NAD + pool, none of which has been evaluated in a cardiovascular outcome trial.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Cardiovascular Medicine, The 970th Hospital of the Joint Logistic Support Force of the People's Liberation Army, Yantai, China.
- Department of Cardiology, Yantaishan Hospital, Yantai, Shandong, China.
ORCID-Profile: Haiping Du
Zitieren
APA
Jiang, W., & Du, H. (2026). Posttranslational Modification Cross‐Talk in Vascular Cells: Molecular Mechanisms and Therapeutic Implications for Atherosclerosis. Cell Biochemistry and Function, 44(11). https://doi.org/10.1002/cbf.70329
Vancouver
Jiang W, Du H. Posttranslational Modification Cross‐Talk in Vascular Cells: Molecular Mechanisms and Therapeutic Implications for Atherosclerosis. Cell Biochemistry and Function. 2026;44(11). doi:10.1002/cbf.70329
BibTeX
@article{Jiang2026,
author = {Jiang, Weiwei and Du, Haiping},
title = {Posttranslational Modification Cross‐Talk in Vascular Cells: Molecular Mechanisms and Therapeutic Implications for Atherosclerosis},
journal = {Cell Biochemistry and Function},
year = {2026},
volume = {44},
number = {11},
doi = {10.1002/cbf.70329}
}
EUVIMED